CLOSE ×

    Use our advanced search tool to find the exact model you need.

    Model Search  
    2021-eb-hp-secondary-feature

    Experimental Biology

    Visit our booth from April 27-30 to explore our expanded portfolio of research models and services.

    Learn more  
    Group of business people

    Career opportunities at Envigo

    If you would like to become part of the team that shapes our future, then visit our careers portal for our current vacancies.

    Careers Portal  
    product-guide-homepage-sub-web-feature

    Envigo’s 2020 product guide

    Let us help you achieve your unique research goals. Access our 2020-2021 product guide to explore our expanded research models and services.

    Download today  

    Latest events

    Latest news

    Scientific insights

    Society of Toxicology | ToxExpo
    March 12-26, 2021 Toxicologists and scientists will attend the annual ToxExpo virtually to communicate industry-leading ideas and best practices. With live, semi-live, and on-demand offerings, attendees will ...
    AACR | Annual meeting
    April 10-15 and May 17-21, 2021 The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, a...
    Experimental Biology 2021
    April 27-30, 2021 Experimental Biology (EB) is the annual meeting that explores the latest research in anatomy, biochemistry and molecular biology, investigative pathology...
    All latest events  
    Envigo to acquire research models business unit from Horizon
    Allows Envigo, a leading supplier of standard research models, to offer transgenic research models and associated services to its global customer base Horizon transgenic model generation and contract breeding expertis...
    LabCorp and Envigo complete innovative transactions
    LabCorp acquires Envigo’s global nonclinical contract research business, Envigo acquires LabCorp’s Covance Research Products business Burlington, N.C., and Indianapolis, Ind. — June 3, 2019 — LabCorp® (NYSE: LH),...
    LabCorp and Envigo sign innovative agreement to expand Covance's nonclinical drug development capabilities and create an independent research models provider
    LabCorp will purchase Envigo’s nonclinical contract research services business, expanding the global reach and capabilities of Covance’s nonclinical drug development business Envigo’s research models...
    All latest news  
    White paper

    The Negative Impacts of Pinworms in Laboratory Animal Research

    Pinworms are an insidious and common threat to research utilizing laboratory mice and rats. This pest can adversely affect the reproducibility and reliability of research findings. Moreover, the parasitic load and adverse effects caused by pinworms can be even more pronounced in immunodeficient animals.

    Case study

    Cannulock™ Buttons Extend Catheter Patency in Rodents

    Looking to enhance the 3Rs and increase catheter patency at the same time? Cannulock™ Buttons can help. This innovative closed system improves animal and technician welfare while increasing catheter patency.

    White paper

    PDX, CDX and Allograft Growth in the R2G2® Mouse

    Three recent studies made it clear: the R2G2® mouse is well suited for preclinical cancer studies that generate PDX, CDX and allograft models. The R2G2® mouse exhibited reduced radiosensitivity compared to NSGTM mice and tolerated estrogen supplementation and three standard-of-care chemotherapy drugs reasonably well. Moreover, as compared to other traditionally used immunodeficient strains, the R2G2® mouse had higher take rates and more favorable tumor growth.

    All Scientific Insights